CORT Competitors
Corcept Therapeutics Incorporated
$73.71
-$0.82(-1.10%)
32
Overall
25
Value
18
Tech
55
Quality
Market Cap
$8.07B
Volume
847.07K
52W Range
$28.66 - $126.38
Target Price
$134.33
CORT competitors: JNJ, BMY, NVS, LLY, PFE. Corcept Therapeutics Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
CORT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $284.45 | $675.03B | $11.12 | 1.86% | 65 |
| BMY Bristol-Myers Squibb Company | $62.61 | $128.59B | $6.44 | 4.02% | 69 |
| NVS Novartis AG | $160.11 | $305.91B | $9.04 | 2.98% | 68 |
| LLY Eli Lilly and Company | $1435.05 | $1.35T | $35.35 | 0.47% | 63 |
| PFE Pfizer Inc. | $28.89 | $167.86B | $3.05 | 4.46% | 65 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $73.71 | -1.1% | 847.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW